autoimmune Conference-Coverage

Conference Coverage

Immune-mediated Inflammatory Diseases: Past and Current Treatments

04/26/2023

Jessica Garlewicz, Digital Managing Editor

Christopher T. Ritchlin, MD, MPH, provided the keynote kickoff for the Interdisciplinary Autoimmune Summit virtual meeting April 26 by addressing advances in the treatment of immune-mediated inflammatory diseases.

Christopher T. Ritchlin, MD,...

04/26/2023

The Dermatologist

Conference Coverage

Inflammatory Skin Conditions: Prevention of Cardiovascular Disease

04/26/2023

Being more aggressive in managing traditional cardiovascular risk factors among patients with more severe psoriasis requires a team-based approach involving the dermatologist, cardiologist, and primary care providers.

Being more aggressive in...

04/26/2023

Autoimmune

Conference Coverage

JAK Inhibitor Safety for Atopic Dermatitis

04/26/2023

Riya Gandhi, MA, Associate Editor

On the first day of the 2023 Interdisciplinary Autoimmune Summit, Peter Lio, MD, FAAD, presented his session, “JAK Inhibitor Safety in the Treatment of Atopic Dermatitis (AD): Evaluating the Long-Term Data.”

On the first day of the 2023...

04/26/2023

The Dermatologist

Conference Coverage

Predictions on the Future of Dermatology

04/26/2023

Coleen Stern, MA, Senior Managing Editor

Joel M. Gelfand, MD, MSCE, and Joseph R. Merola, MD, MMSc, explored trends in dermatology practice organization and the impact of drug development, research priorities, and emerging technology on clinical practice.

Joel M. Gelfand, MD, MSCE, and...

04/26/2023

The Dermatologist

Conference Coverage

Leonard Calabrese, DO, on COVID-19 and the Immunocompromised Patient

04/26/2023

Priyam Vora, Associate Editor

Leonard Calabrese, DO, discussed the risks and complications of SARS-CoV-2 among immunocompromised patients at the Interdisciplinary Autoimmune Summit virtual session.

Leonard Calabrese, DO, discussed...

04/26/2023

Autoimmune

Conference Coverage

Prurigo Nodularis: Features and Burden of Disease

04/26/2023

Jessica Garlewicz, Digital Managing Editor

Shawn Kwatra, MD, described the clinical features, pathophysiology, and burden of disease in prurigo nodularis.

Shawn Kwatra, MD, described the...

04/26/2023

The Dermatologist

Conference Coverage

Stephen B. Hanauer, MD, on Human Models of Inflammatory Bowel Disease

04/26/2023

Dr Hanauer emphasizes how a number of potential human models can be used to more accurately evaluate the pathogenesis of inflammatory bowel disease by studying human patients rather than mice.

Dr Hanauer emphasizes how a...

04/26/2023

Autoimmune

Conference Coverage

Megan Meier, MD, on Direct-to-Patient Screening of PsA

04/11/2023

Priyam Vora, Associate Editor

Data from the Psoriasis Epidemiology Screening Tool survey found that evaluation by a rheumatologist was beneficial in patient-driven psoriatic arthritis screening.

Data from the Psoriasis...

04/11/2023

Rheumatology & Arthritis

Conference Coverage

Saakshi Khattri, MD, MBBS, on the Impact of Risankizumab on Enthesitis and Dactylitis in PsA

03/07/2023

Rebecca Mashaw, Managing Editor

Rebecca Mashaw, Managing Editor ...

Results from the KEEPsAKE 1 and 2 trials demonstrated the efficacy of risankizumab in achieving and maintaining resolution of dactylitis and enthesitis among patients with psoriatic arthritis.

Results from the KEEPsAKE 1 and...

03/07/2023

Rheumatology & Arthritis

Conference Coverage

Laura Coates, MBBS, on Upadacitinib Vs Adalimumab on RAPID3 Among Patients With Psoriatic Arthritis

02/22/2023

Dr Coates presented a poster at ACR Convergence examining the efficacy of upadacitinib vs adalimumab in treating psoriatic arthritis, using the RAPID3 tool to assess disease activity.

Dr Coates presented a poster at...

02/22/2023

Rheumatology & Arthritis

Conference Coverage

Popular Articles

Stay In the Know

Specialties

Events

Year Round Education

HMP Global Products